Molnupiravir, an Oral Antiviral Treatment for COVID-19

BACKGROUND: Easily distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report the results of a Phase 2a trial evaluating the saf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Fischer, William, Eron, Joseph J., Holman, Wayne, Cohen, Myron S., Fang, Lei, Szewczyk, Laura J., Sheahan, Timothy P, Baric, Ralph, Mollan, Katie R., Wolfe, Cameron R., Duke, Elizabeth R., Azizad, Masoud M., Borroto-Esoda, Katyna, Wohl, David A., Loftis, Amy James, Alabanza, Paul, Lipansky, Felicia, Painter, Wendy P.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8219109/
https://ncbi.nlm.nih.gov/pubmed/34159342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.06.17.21258639
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados